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Abstract
Background—Depressive symptoms and poor social support are predictors of increased
morbidity and mortality in patients with heart failure (HF). However, the combined contribution of
depressive symptoms and social support event-free survival of patients with HF has not been
examined.
Objective—To compare event-free survival in four groups of patients with HF stratified by
depressive symptoms and perceived social support.
Method—A total of 220 patients completed the Beck Depression Inventory-II and the
Multidimensional Perceived Social Support Scale and were followed for up to 4 years to collect
data on death and hospitalizations.
Results—Depressive symptoms (HR=1.73, P=.008) and perceived social support (PSS)
(HR=1.51, P=.048) were independent predictors of event-free survival. Depressed patients with
low PSS had 2.1 times higher risk of events than non-depressed patients with high PSS (P=.003).
Conclusion—Depressive symptoms and poor social support had a negative additive effect on
event-free survival in patients with HF.
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More than 5.8 million Americans currently suffer from heart failure (HF).1 Life expectancy
of patients with HF is short, and morbidity and mortality rates are increasing.2–3 In the last
two decades, hospitalization rates due to worsening HF symptoms increased 26%.1
Mortality rates within 5 years of initial HF diagnosis are 59% and 45% for male and female
patients aged between 65 to 75 years, respectively.1
Depression is a state of low mood characterized by sad feelings, despair, and
discouragement.4 Depressive symptoms are a common psychological problem in patients
with HF. Almost two-thirds to three-quarters of patients with HF suffer from some degree of
depressive symptoms. Of these, up to 35% of patients report the highest levels of depression,
5–7 while another 27% to 35% of patients report at least mild depressive symptoms.5–6 A
meta analysis that examined at 27 HF studies found that prevalence of depressive symptoms
in patients with HF ranges from 9 to 60% and overall prevalence was 20.1%.8
Most patients with HF need family member support or care to effectively manage their
condition. Thus, millions of family members, friends and significant others are expected to
be the core support system in the long-term care of patients with HF. Social support can be
defined as the quality and functional content of social relationships—this consists of
supportive behaviors that provide emotional, instrumental, informational and appraisal
support.9 Researchers have found that poor social support from family, friends, significant
others and formal care providers may be a factor in worsening health outcomes and quality
of life in patients with HF.10–13
Evidence from major studies demonstrates that both depressive symptoms and lack of (or
poor) social support are independent predictors of poor outcomes in patients with coronary
heart disease when depressive symptoms and social support are investigated individually.5,
8, 14–16 Among patients with HF, patients with depressive symptoms had two to three times
greater risk of death and rehospitalization than patients without depressive symptoms.8
Similarly, unmarried patients with HF had two times higher risk of mortality and morbidity
than married patients.15 Furthermore, it is estimated that one-fifth of HF hospitalizations are
due to poor social support.16
The occurrence of both poor social support and depressive symptoms may have an additive
effect on morbidity and mortality. In two studies,15,16 both depressive symptoms and social
support were independent predictors of mortality in patients with HF. However, further
examination of these two risk factors is needed to clarify the combined contribution of
depressive symptoms and social support on health outcomes of patients with heart failure.
The purpose of this study was to compare event-free survival in patients with HF who were
stratified into four groups: (a) depressive symptoms with low perceived social support
(PSS), (b) depressive symptoms with high PSS, (c) no-depressive symptoms with low PSS,
and (d) no-depressive symptoms with high PSS.
Methods
Sample
The Research and Intervention for Cardiopulmonary Health Heart Program at the College of
Nursing, University of Kentucky, simultaneously conducted three prospective, longitudinal
studies in outpatient clinics and a private hospital in Central Kentucky. The first study
focused on exploring potential mechanisms for the association between depression,
increased morbidity and mortality in HF.17 The second study examined relationships among
nutritional intake, inflammation, and outcomes in patients with HF.18 The third study tested
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the effectiveness of biofeedback-relaxation training on outcomes in patients with HF; we
used baseline data from this study and excluded patients who received the intervention.
Patients in all three studies were recruited using the same inclusion and exclusion criteria,
although each study had unique primary research questions. After physician and nurse
practitioner referral, patient eligibility was confirmed by reviewing medical charts with
standardized screening criteria. Patients were eligible to participate if they had a confirmed
diagnosis of chronic HF, were in a stable HF condition, and had not experienced an acute
myocardial infarction in the past 3 months. Patients were excluded if they had valvular or
peripartum HF etiology, were referred for heart transplantation, or end-stage cancer, liver or
renal disease. Of the screened eligible patients, 32% participated in one of the three studies
from January 2004 to December 2006. For this study, we included only 220 unique patients
who (1) participated in only one study, (2) completed questionnaires of depressive
symptoms and perceived social support at baseline and (3) were followed for up to four
years to collect data on death and hospitalization.
Measures
Depressive symptoms—An inclusive approach was used to measure depressive
symptoms,(i.e. patients were considered to have depressive symptoms, even if the patient
had depressive somatic symptoms that could be attributed to HF).19 Other researchers have
found that this inclusive method is sensitive, reliable, and predicts long-lasting depression in
the medically ill.20 Depressive symptoms were assessed with the Beck Depression
Inventory-II (BDI-II), a valid and reliable instrument for the measurement of depressive
symptoms.21–22 The BDI-II measures the presence and severity of depressive symptoms
corresponding to criteria for depressive disorders listed in the American Psychiatric
Association’s Diagnostic and Statistical Manual of Mental Disorder (Fourth Edition);
however, this instrument is not used to diagnose clinical depression.23 The BDI-II predicts
outcomes of mortality and hospitalizations in coronary heart disease patients and patients
with HF.14, 24–26 The BDI-II has a total of 21 items rated on a likert scale from 0 to 3 and
the total score can range from 0 to 63.22–23, 27–28 Patients who score 14 or above are
considered to have clinically significant depressive symptoms.23 Cronbach’s alpha wasf88
in our sample.
Social support—Social support was defined as self-reported perceived social support
from family, friends, or others and was assessed using the Multidimensional Perceived
Social Support Scale (MPSSS).29 The MPSSS includes 12 items and is rated on a 7-point
Likert scale from 1(very strongly disagree) to 7 (very strongly agree). The total score is a
sum of 12 items that ranges from 12 to 84; higher total scores indicate higher levels of
perceived social support from family, friends, or significant others. Researchers have found
evidence for reliability of this instrument, with Cronbach’s alphas ranging from .85 to .91.29
In our study the Cronbach’s alpha was .94.
Event-free survival—The primary outcome in our study was event-free survival, defined
as time to a combined end point of all cause hospitalization or death. Event-free survival—
which reflects both mortality and hospitalizations—was chosen as the primary end point to
capture a more complete picture of disease progress rather than mortality alone.30–32
Monthly follow-up phone calls and hospital administrative databases were reviewed to
identify events. Hospitalizations were verified with hospital records; dates and causes of
death were determined by hospital records, family interview, and death certificates. A
written protocol for event coding was developed by the investigators. The events were coded
independently by two Master’s-prepared cardiac nurses who were blinded to depressive
symptoms and social support scores. The data codes were compared for agreement; any
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discrepancies or disagreements were reviewed with the principal investigators of the three
studies, who together made the final coding decision.
Other variables of interest—In order to describe sample demographic and clinical
variables, we also collected demographics (i.e., age, gender, education, ethnicity, marital
status) and clinical characteristics (etiology, left ventricular ejection fraction, prescribed
medications, comorbidities).
We measured subjective functional status using New York Heart Association (NYHA) class
and the Duke Activity Status Index (DASI).33 NYHA functional class was determined by
careful patient interview. Based on patient’s report of how able they were to perform their
usual activities, they were assigned a NYHA classification of I (ordinary physical activity
causes no symptoms of fatigue, dyspnea, angina or palpitations), II (symptoms with ordinary
physical activity that slightly limit physical activity), III (symptoms occur with less than
ordinary physical and markedly limit activity), or IV (symptoms occur even at rest).34 All
research nurses completed a standard training protocol to meet 100% inter-rater reliability
and intra-rater reliability.
The DASI is widely used to assess cardiovascular patients’ functional capabilities for
activities of daily living. The 12 items of the DASI have three response categories (i.e., ‘not
done because of health reason’, ‘done with difficulty’, and ‘done without difficulty’) to
assess the difficulty of each activity. The total score is calculated based on a weighted score
for each activity and ranges from 0 to 58.2. Higher total scores indicate better functional
status. Cronbach’s alpha coefficient for the DASI was .84 in this study.
Procedure
After approval of the Institutional Review Board for each study, trained research nurses
screened medical charts (in compliance with the Health Insurance Portability and
Accountability Act) to find potential eligible patients who were referred to the study by
doctors or nurse practitioners. Trained nurse researchers contacted eligible patients at a
clinic visit and obtained signed informed consent. Demographic and clinical characteristics
were collected by patient interview and by reviewing patients’ medical charts using a
structured questionnaire. All participating patients completed questionnaires and were asked
to record their hospitalization history in a log book. We followed up with monthly phone
calls to collect death or hospitalization histories and confirmed all dates and causes of death
and hospitalization by reviewing medical charts. We obtained death certificates and
reviewed county death records if necessary.
Data analysis
Data analysis took place in two main steps. In the first step, we confirmed that depressive
symptoms and PSS were independent predictors of event-free survival. , Patients were
grouped into two groups—presence or absence of depressive symptoms—using the standard
cut-point of 14 on the BDI-II. We also grouped patients into high and low perceived social
support (PSS) groups using a median MPSSS score of 73; the median score was used
because there is no recommended cut point for this scale. Kaplan-Meier survival curves, the
log-rank test, and Cox proportional hazards models were used to examine the prediction of
event-free survival for depressive symptoms alone and social support alone, without
controlling for possible confounding variables. A p value of .05 was considered significant
for all analyses.
In the second step, patients were divided into 4 groups using the cut-points described above:
1) depressive symptoms with high PSS, 2) depressive symptoms with low PSS, 3) no
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depressive symptoms with high PSS, and 4) no depressive symptoms with low PSS. We
evaluated differences between the four groups with independent sample t-tests, Chi-square,
and Pearson correlations. We then obtained hazard ratios for each of the four groups using
Cox proportional hazards modeling with and without controlling for age, gender, NYHA
class, and DASI scores. The proportional assumption of the Cox proportional hazard model
for variables was examined using log-minus-log survival plots and scatterplots of Schoenfel
residuals plots.35 The proportionality assumptions for all Cox proportional hazard models in
this study were not violated because there was a steady increasing difference between the
two curves without crossed curves in the log-minus-log survival plots and because
Schoenfel residual plots appeared as a systemic trend over time.35
We conducted a power analysis prior to data collection with NQuery Advisor.36 With a
significance level of 0.05 and at least 90 subjects in each group (ie ‘with depressive
symptoms’ and ‘‘without’ depressive symptom), the power of the log rank test to detect a
significant difference in the combined endpoint distribution between the two subgroups was
estimated to be at least 74% if the ‘with depressive symptoms’ group had a 25% reduction in
the combined endpoint relative to the ‘without depressive symptoms’ group. With addition
of covariates in the Cox proportional hazards model, the power of the regression to detect
significant group difference would be even greater than the corresponding log-rank test
given above. Although we included more than 90 per group in this study (leading to an
increase in estimated power relative to the initial estimate), we are not able to reassess the
power analysis estimates in the light of this sample size increase since post-hoc power
analysis is not statistically valid.37
Results
Sample characteristics are displayed in Table 1. The mean age of the 220 participating
patients was 61 years (SD = 11), similar to other studies of patients with HF.38 The majority
of patients were Caucasian (80%), half were married (56%), and 66% were male. The mean
left ventricular ejection fraction was 34.5%, and 60% of patients were NYHA class level III
or IV, indicating that the majority of the sample had poor functional status. During the
follow-up period, 22 patients (10%) died and 96 patients (44%) were hospitalized. Of the 96
hospitalized patients, 62 patients were readmitted due to HF or other cardiovascular-related
diagnoses.
Depressive symptoms
The mean BDI-II level was 11.5 ± 8.9. Seventy-one patients (32%) had clinically significant
depressive symptoms (BDI-II > 13), and 23% of patients were taking antidepressants at
baseline. As shown in Table 2, patients with depressive symptoms were younger (P < .001),
had lower levels of perceived social support (P < .001), and poorer functional status (P < .
001) than patients without depressive symptoms (Table 2). Patients with depressive
symptoms were more likely to take antidepressants than patients without depressive
symptoms (P < .001). Male and female patients had similar levels of depressive symptoms.
Perceived social support
The mean of the MPSSS was 67.3 ± 17.7 and the median was 73, indicating a moderately
high level of perceived social support. Patients with high perceived social support were
older, married, and had lower levels of depressive symptoms than patients with low levels of
perceived social support (Table 2). The number of patients taking prescribed antidepressants
was similar between patients with high and low social support.
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Depressive symptoms and perceived social support
When we compared the characteristics of the four patient groups stratified by depressive
symptoms and perceived social support, there were differences in age, marital status, NYHA
class and functional status among groups (Table 3). Patients who had no depressive
symptoms and high social support were older compared to the other groups. Regardless of
depressive symptoms, patients with high social support were more likely to be married and
have higher functional status than patients with low social support. Regardless of social
support, patients with depressive symptoms were more likely to be NYHA class level III or
IV patients than patients without depressive symptoms. Depressive symptoms were
negatively correlated with perceived social support; higher depressive symptom levels were
associated with low perceived social support levels (r = −.309, P < .001).
Individual variables and event-free survival
As demonstrated by the Kaplan-Meier survival analyses, patients with depressive symptoms
had shorter event-free survival than patients without depressive symptoms (P = .008, Figure
1). The Cox proportional hazards model results indicated that patients with depressive
symptoms had a 73% higher risk of events than patients without depressive symptoms (HR
= 1.73; 95% CI: 1.15 – 2.61; Table 4). Patients with high PSS had longer event-free survival
than patients with low PSS (P= .046, Figure 2). Patients with low PSS had a 50 % higher
risk of events compared to patients with high PSS (HR = 1.5; 95% CI: 1.00 – 2.26; Table 4).
Combined effects of depressive symptoms and poor social support
Patients with depressive symptoms and low perceived social support experienced the
shortest event-free survival among all groups (P = .04). In the Cox proportional hazards
model (Figure 3), patients with depressive symptoms and low PSS had 2.1 times higher risk
of events compared to the patients with no depressive symptoms and high PSS (Table 4).
When we controlled for age, gender, NYHA class, and functional status, patients with
depressive symptoms and low PSS had 1.8 times higher risk of events than patients with no
depressive symptoms and high PSS (Table 5). Patients with no depressive symptoms and
low perceived social support and patients with depressive symptoms and high perceived
social support experienced similar hazard ratios for event-free survival (Table 4 and
5).Together, the survival curve (Figure 3) and hazard ratios (Table 4 and 5) indicate a
synergistic effect of depressive symptoms and low perceived social support on event-free
survival.
Discussion
In this study, the rate of depressive symptoms and the under-treatment of depressive
symptoms are consistent with findings from other researchers.8, 38 We found that both
depressive symptoms and perceived social support were independent predictors of
hospitalization and death. Our finding that depressive symptoms are an independent
predictor of event-free survival of patients with HF is similar to findings from other
investigators.5, 14 Patients with depressive symptoms in this study had a 73% higher risk of
hospitalization and death than patients without depressive symptoms. Also consistent with
prior investigators, 39 we found that perceived social support from family and friends was an
independent predictor of event-free survival. Patients with low perceived social support had
a 50% higher risk of hospitalization and death than patients with high perceived social
support.
The most compelling finding of this study was the synergistic effect of depressive symptoms
and low perceived social support on event-free survival in patients with HF. Patients with
only one risk factor—either depressive symptoms or perceived low social support—had a
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similar risk of hospitalization or death as patients with neither risk factor. In contrast,
patients with both risk factors had double the risk of hospitalization or death compared to
patients with neither risk factor. Even when we controlled for possible confounding factors
(i.e., age, gender, NYHA class, and functional status), the risk of hospitalization and death
for patients with both risk factors was still 1.8 times higher than patients with neither risk
factor.
In the context of depression, investigators have not clearly explained how social support
improves outcomes; however, two mechanisms have been suggested: a buffer effect or a
direct effect on outcomes.40–42 The buffer effect hypothesizes that positive social support
protects patients from potentially distressful experience or depression. In contrast, the direct
effect suggests that positive social support has a direct impact on improving outcomes
despite the presence of stress or depression. Given that both depressive symptoms and poor
social support were independent and synergistic predictors of event-free survival, our
findings indicate that social support had a direct effect on outcomes.
To date, only four groups of investigators25, 43–45 have investigated the effects of both
depressive symptoms and social support on mortality outcomes in patients with
cardiovascular disease. Two research teams investigated the effects in acute myocardial
infarction patients25, 45 and the other two groups of investigators described effects in
patients with HF.43–44 Depressive symptoms had a consistently negative impact on
outcomes in all four studies, whereas social support did not have a consistent impact.
Social support failed to predict mortality in patients with acute myocardial infarction25, 45
but did predict mortality in patients with HF.43–44 Frasure-Smith et al.25 conducted a
prospective study in 877 post myocardial infarction patients for one year. They found that
patients with depressive symptoms had 3.3 times higher risk of mortality than patients
without depressive symptoms while perceived social support failed to predict mortality
outcomes independently. In the Enhancing Recovery in Coronary Heart Disease
(ENRICHD) study, Lett and colleges45 enrolled 2481 patients with acute myocardial
infarction and found that patients with depressive symptoms had 2.25 times higher risk of
mortality than patients without depressive symptoms, but perceived social support did not
predict mortality. However, researchers have reported an interaction effect between
perceived social support and depressive symptoms. Frasure-Smith and colleagues25 found
that only patients who were depressed with perceived low social support had increased risk
of cardiac mortality. Similarly, Lett and colleagues45 reported that the best survival rate
occurred only in patients who had perceived high social support and no depressive
symptoms.
On the other hand, in patients with HF, two groups of investigators have found that social
support independently predicted mortality outcomes, as did depressive symptoms.
Friedmann and colleagues44 found that both depressive symptoms (HR = 2.25) and social
isolation (HR = .55) as were independent predictors of mortality in 153 patients with HF.
Chung and colleagues43 found that both depressive symptoms and marital status—one
indicator of social support—were strong independent predictors of cardiac event-free
survival in patients with HF. Unmarried patients had 3.9 times higher risk of cardiac events
than married patients with HF, while depressed patients had 3.7 times higher risk of cardiac
events than non-depressed patients.43
Although these prior studies have identified social support and depressive symptoms as
important predictors of health outcomes in patients with HF, these researchers did not report
whether there was a combined effect of both predictors on outcomes. In our study, we
advanced the state of the science by determining the combined impact of depressive
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symptoms and perceived social support on event-free survival in patients with HF.
Importantly, we also found that perceived social support had a similar hazard ratio
depressive symptoms for event-free survival similar to what other investigators have found
in patients with HF.43–44
One of the possible reasons for inconsistent findings on social support and outcomes
between acute myocardial infarction patients and patients with HF could be explained by
stability of social support in the acute or chronic situation. Myocardial infarction is a
potentially life-threatening event, but the experience is often acute and short-term. An acute
event may motivate individuals to temporarily enhance social networks. Acute events may
also motivate support persons to rally and provide more support for the time being.
According to Pedersen and colleagues,46 patients with a first myocardial infarction
experienced a decrease in levels of social support from 4–6 weeks to 9-months. In contrast,
HF is a chronic condition that requires long-term support. This chronic nature of HF may
erode the strength or quality of social support networks because of the long term
commitment involved. It has been reported that caregivers of patients with HF experience
severe burden and emotional distress.47–50 The quality of social support or the size of social
networks may also decrease over time as the caregiver’s burden increases. In this study, it is
not known whether the quality of social support changed because perceived social support
was assessed at only one time point. However, patients with HF in this study did not have
any hospitalizations within the 3 months prior to participation in this study, thus the
perceived social support likely reflect their usual level of social support. Longitudinal
studies are needed to determine whether changes in perceived social support affect outcomes
of patients with HF and depressive symptoms.
Non-pharmacological interventions such as relaxation therapy and cognitive behavioral
therapy have been proposed as possible treatments for depressive symptoms in patients with
HF,8, 51 but few investigators have systemically investigated interventions to improve social
support in patients with HF.52–53 Only one intervention study related to both depressive
symptoms and improved social support was found.54 The ENRICHD investigators reported
that cognitive behavioral therapy was effective in improving depressive symptoms and
social support in myocardial infarction patients, but the intervention did not reduce the risk
of six-month mortality or recurrent infarction outcomes.54 It is possible that cognitive
behavioral therapy, which can focus on improving depressive symptoms and reinforcing
social support, may be an intervention that improves long term mortality and morbidity
outcomes of patients with HF. However, research on this intervention in patients with HF is
still in early stages; further testing is needed before cognitive behavioral therapy can be
recommended.55
This study contributes to evidence that suggests perceived social support is an independent
predictor of mortality and morbidity in patients with HF even when different
conceptualizations and measures of social support are used.44, 56 In this study, we
conceptualized social support as the subjective perception of support from family, friends,
and significant others (using the MPSS), rather than structured social support, emotional
support, functional support or social networks. Although scholars have raised concerns that
different conceptualizations of social support may contribute to inconsistent findings, we
found that our results appeared to be consistent with previous studies despite the differing
definitions of social support. Nevertheless, additional longitudinal investigations are needed
to examine the effects of various types of support and the amount of social support needed
to influence health outcomes in patients with HF. Interventions that improve current social
network connections, develop new social network connections, and utilize community
health workers may help provide effective social support. Further research is needed to
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assess the efficacy of interventions such as these in patients with HF—especially in those
with depressive symptoms.
Several limitations should be noted. First, we did not assess patients’ use of antidepressants
during the follow up period, and we also do not know whether depressive symptoms
improved. Second, we do not know whether patients’ support systems or quality of social
support were maintained after baseline assessment. Nonetheless, our findings suggest that
depressive symptoms and perceived social support as measured at baseline assessment
predict event-free survival.
Conclusions
Depressive symptoms and poor social support had a synergistic, negative effect on event-
free survival in patients with HF. These finding emphasize the crucial role of both
depressive symptoms and social support on negative outcomes of patients with HF.
Interventions to improve clinical outcomes in patients with HF should target both depressive
symptoms and perceived poor social support, as the synergistic effects of these factors may
lead to greater health risks in this population.
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Kaplan-Meier event-free survival curve for depressive symptoms groups
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Kaplan-Meier event-free survival curve for perceived social support groups
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Event-free survival for patients who were stratified by depressive symptoms and perceived
social support.
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Table 1
Demographic and clinical characteristics of patients with heart failure (N = 220)
Characteristics M ± SD/n (%)
Age, years 60.9 ± 11.3
Male, gender 146 (66.4%)
Caucasian 176 (80.0%)
Married 124 (56.3%)
Ischemic etiology 118 (53.6%)
Prior bypass surgery 64 (29.1%)
Co-morbidity of DM 98 (44.5%)
Co-morbidity of hypertension 164 (74.5%)
Prior MI 119 (54.1%)
NYHA Class II 88 (40.0%)
 Class III 101 (45.9%)





Antidepressant use 51 (23.2%)
ICD 79 (35.9%)
Body mass index 31.5 ± 7.2
Death (%) 22 (10.1%)
Cardiac hospitalization 62 (28.2%)
All cause of hospitalization 96 (43.6%)
DM = Diabetes Mellitus; MI = Myocardial Infarction; NYHA = New York Heart Association; ACEI =Angiotensin-converting enzyme inhibitors;
ARB = Angiotensin II Receptor Blockers; ICD = Implantable Cardioverter Defibrillator.
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